Inmune Stock Technical Analysis

INMB
 Stock
  

USD 9.41  0.29  3.18%   

As of the 14th of August 2022, Inmune Bio retains the Risk Adjusted Performance of 0.1514, market risk adjusted performance of 0.5068, and Downside Deviation of 6.38. Inmune Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have collected data for nineteen technical drivers for Inmune Bio, which can be compared to its competitors. Please check out Inmune Bio maximum drawdown, and the relationship between the information ratio and downside variance to decide if Inmune Bio is priced fairly, providing market reflects its last-minute price of 9.41 per share. Given that Inmune Bio has jensen alpha of 0.5313, we strongly advise you to confirm Inmune Bio's regular market performance to make sure the company can sustain itself at a future point.
  

Inmune Bio Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Inmune, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Inmune
Inmune Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Inmune Bio Analyst Consensus

Target PriceAdvice# of Analysts
37.0Strong Buy2Odds
Inmune Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Inmune analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Inmune stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Inmune Bio, talking to its executives and customers, or listening to Inmune conference calls.
Inmune Analyst Advice Details
Inmune Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Inmune Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Inmune Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Inmune Bio Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty-one with a total number of output elements of thirty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Inmune Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
.

Inmune Bio Trend Analysis

Use this graph to draw trend lines for Inmune Bio. You can use it to identify possible trend reversals for Inmune Bio as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Inmune Bio price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Inmune Bio Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Inmune Bio applied against its price change over selected period. The best fit line has a slop of   0.06  , which means Inmune Bio will continue generating value for investors. It has 122 observation points and a regression sum of squares at 154.02, which is the sum of squared deviations for the predicted Inmune Bio price change compared to its average price change.

About Inmune Bio Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Inmune Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Inmune Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Inmune Bio stock first instead of the macroeconomic environment surrounding Inmune Bio. By analyzing Inmune Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Inmune Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Inmune Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2010 2021 2022 (projected)
Accounts Payable Turnover0.0097030.06750.0728
Receivables Turnover0.0096580.05490.0592

Inmune Bio August 14, 2022 Technical Indicators

Most technical analysis of Inmune help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Inmune from various momentum indicators to cycle indicators. When you analyze Inmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Inmune Bio August 14, 2022 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Inmune stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Please see Risk vs Return Analysis. Note that the Inmune Bio information on this page should be used as a complementary analysis to other Inmune Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Inmune Stock analysis

When running Inmune Bio price analysis, check to measure Inmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmune Bio is operating at the current time. Most of Inmune Bio's value examination focuses on studying past and present price action to predict the probability of Inmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmune Bio's price. Additionally, you may evaluate how the addition of Inmune Bio to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Is Inmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmune Bio. If investors know Inmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
168.9 M
Quarterly Revenue Growth YOY
39.75
Return On Assets
-0.26
Return On Equity
-0.58
The market value of Inmune Bio is measured differently than its book value, which is the value of Inmune that is recorded on the company's balance sheet. Investors also form their own opinion of Inmune Bio's value that differs from its market value or its book value, called intrinsic value, which is Inmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmune Bio's market value can be influenced by many factors that don't directly affect Inmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Inmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.